Home - Products - GPCR/G Protein - S1P Receptor - Vibozilimod

Vibozilimod

CAS No. 1403232-33-6

Vibozilimod( —— )

Catalog No. M35071 CAS No. 1403232-33-6

Vibozilimod (SCD-044) is S1P receptor-1 (S1PR1) agonist .

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	164	In Stock
10MG	226	In Stock
25MG	392	In Stock
50MG	554	In Stock
100MG	759	In Stock
200MG	1004	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Vibozilimod
Note

Research use only, not for human use.
Brief Description

Vibozilimod (SCD-044) is S1P receptor-1 (S1PR1) agonist .
Description

Vibozilimod (SCD-044, example 33) is a S1p1 receptor agonist (extracted from patent WO2012140020A1).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

S1P Receptor
Recptor

S1P Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

1403232-33-6
Formula Weight

542.07
Molecular Formula

C29H36ClN3O5
Purity

>98% (HPLC)
Solubility

In Vitro:?Ethanol : 1.92 mg/mL (3.54 mM; ultrasonic and warming and adjust pH to 5 with HCl and heat to 60°C)
SMILES

COCCOCC1(CCN(Cc2ccc(cc2)-c2noc(n2)-c2ccc(CC(C)C)c(Cl)c2)CC1)C(O)=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Marc Capet, et al. Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists. Patent. WO2012140020A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Amgen-23

Amgen-23 is a selective and highly potent sphingosine kinase 1 (SPHK1) inhibitor that inhibits SPHK2 and can be used in anticancer research.
GLPG2938

GLPG2938 is a potent and selective antagonist of S1P2.
BMS-960

BMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.

Sign In Join Free